WebHaleon was established on 18 July 2024 as a corporate spin-off from GSK. [7] Sir David Lewis is chairman, with Brian McNamara as CEO. [8] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2024. WebFeb 24, 2024 · Haleon separated from the pharmaceutical giant in July. Its shares have risen 6% since then, giving it a market value of 30 billion pounds ($36 billion). GSK still owns about 13% of Haleon’s...
GSK to name consumer healthcare unit
WebFeb 22, 2024 · GSK. When GlaxoSmithKline spins off its consumer health unit later this year, the British pharmaceutical giant’s standalone business will become … WebJul 13, 2024 · Once Haleon makes it to the open market, current shareholders will own the majority of the business. GSK plans to retain a near 14% stake in the business, which it … kore reinforced leather belt
Sanofi et Haleon s’intéressent aux bouteilles en papier
WebHaleon was established on 18 July 2024 as a corporate spin-off from GSK. Sir David Lewis is chairman, with Brian McNamara as CEO. Haleon is listed on the London Stock … WebJun 1, 2024 · Following the demerger and listing of Haleon on the London Stock Exchange (LSE), which is expected to occur in July 2024, Pfizer will continue to hold a 32% ownership interest in Haleon. WebJul 18, 2024 · GlaxoSmithKline plc (LSE:GSK) completed the spin-off of at least 54.4% stake in Consumer Healthcare business on July 18, 2024. As of January 31, 2024, John Young, Non-Executive Director and representative of Pfizer Inc. will be stepping down from the Board of the Haleon with effect from 28 February 2024. Ghada El Ehwany and … manifest consulting group address